100 related articles for article (PubMed ID: 437261)
21. Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging.
Thal LJ; Horowitz SG; Dvorkin B; Makman MH
Brain Res; 1980 Jun; 192(1):185-94. PubMed ID: 7378779
[TBL] [Abstract][Full Text] [Related]
22. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
Seiler MP; Markstein R
Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
[TBL] [Abstract][Full Text] [Related]
23. Evidence for an exclusive localization of 3H-ADTN binding sites to postsynaptic nerve cells in the striatum of the rat.
Fuxe K; Hall H; Köhler C
Eur J Pharmacol; 1979 Oct; 58(4):515-7. PubMed ID: 510387
[No Abstract] [Full Text] [Related]
24. Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G
Eur J Pharmacol; 1996 May; 304(1-3):49-54. PubMed ID: 8813583
[TBL] [Abstract][Full Text] [Related]
25. Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism.
Ross SB
J Neurochem; 1991 Jan; 56(1):22-9. PubMed ID: 1824780
[TBL] [Abstract][Full Text] [Related]
26. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
Makman MH; Dvorkin B; Klein PN
Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
[TBL] [Abstract][Full Text] [Related]
27. Stereospecific effects of ascorbic acid and analogues on D1 and D2 agonist binding.
Tolbert LC; Morris PE; Spollen JJ; Ashe SC
Life Sci; 1992; 51(12):921-30. PubMed ID: 1355577
[TBL] [Abstract][Full Text] [Related]
28. Affinity shifts induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors.
Urwyler S
J Neurochem; 1987 Nov; 49(5):1415-20. PubMed ID: 2959751
[TBL] [Abstract][Full Text] [Related]
29. Kinetic and pharmacological profiles of the in vitro binding of the potent dopamine agonist [3H]N,N-dipropyl-5,6-dihydroxy-2-aminotetralin to rat striatal membranes.
Mulder TB; Grol CJ; Dijkstra D; Horn AS
Eur J Pharmacol; 1985 May; 112(1):73-9. PubMed ID: 4018139
[TBL] [Abstract][Full Text] [Related]
30. [3H]dopamine binds to D-1 and D-2 receptors in rat striatum.
Bacopoulos NG
Eur J Pharmacol; 1983 Feb; 87(2-3):353-6. PubMed ID: 6132831
[TBL] [Abstract][Full Text] [Related]
31. Effect of calmodulin on catecholamine-linked adenylate cyclase activity in rat striatum and cerebral cortex.
Gnegy ME; Hultin T; Treisman G
Adv Biochem Psychopharmacol; 1980; 21():125-31. PubMed ID: 6246737
[No Abstract] [Full Text] [Related]
32. A new dopaminergic prodrug.
Horn AS; de Kaste D; Dijkstra D; Rollema H; Feenstra M; Westerink BH; Grol C; Westerbrink A
Nature; 1978 Nov; 276(5686):405-7. PubMed ID: 714167
[No Abstract] [Full Text] [Related]
33. The use of R(+)-ADTN in dopamine receptor binding assays.
Davis A; Poat JA; Woodruff GN
Eur J Pharmacol; 1980 May; 63(2-3):237-8. PubMed ID: 6155278
[No Abstract] [Full Text] [Related]
34. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
Wallace DR; Booze RM
J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
[TBL] [Abstract][Full Text] [Related]
35. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions.
Fujita N; Saito K; Iwatsubo K; Hirata A; Noguchi Y; Yoshida H
Brain Res; 1980 May; 190(2):593-6. PubMed ID: 7370810
[No Abstract] [Full Text] [Related]
36. Isomeric selectivity at dopamine D3 receptors.
Baldessarini RJ; Kula NS; McGrath CR; Bakthavachalam V; Kebabian JW; Neumeyer JL
Eur J Pharmacol; 1993 Aug; 239(1-3):269-70. PubMed ID: 8223909
[TBL] [Abstract][Full Text] [Related]
37. In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
Kung MP; Kung HF; Chumpradit S; Foulon C
Eur J Pharmacol; 1993 Apr; 235(1):165-6. PubMed ID: 8519278
[TBL] [Abstract][Full Text] [Related]
38. Reduced dopaminergic binding during aging in the rodent striatum.
Severson JA; Finch CE
Brain Res; 1980 Jun; 192(1):147-62. PubMed ID: 6155174
[TBL] [Abstract][Full Text] [Related]
39. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
Booze RM; Wallace DR
Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
[TBL] [Abstract][Full Text] [Related]
40. [3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.
List SJ; Seeman P
J Neurochem; 1982 Nov; 39(5):1363-73. PubMed ID: 7119802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
